These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16375762)

  • 21. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
    Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
    Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.
    Adachi A; Fukunaga A; Horikawa T
    Int J Dermatol; 2004 Aug; 43(8):597-9. PubMed ID: 15304187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premix insulins in type 1 diabetes: the coming of degludec/aspart.
    Rendell M
    Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):341-348. PubMed ID: 30789066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous insulin allergy responsive to oral desensitisation and aspirin.
    Holdaway IM; Wilson JD
    Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1565-6. PubMed ID: 6439319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
    Pauli G; Purohit A; Oster JP; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
    Clin Exp Allergy; 2000 Aug; 30(8):1076-84. PubMed ID: 10931114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
    Heise T; Meiffren G; Alluis B; Seroussi C; Ranson A; Arrubla J; Correia J; Gaudier M; Soula O; Soula R; DeVries JH; Klein O; Bode B
    Diabetes Obes Metab; 2019 Apr; 21(4):1066-1070. PubMed ID: 30565407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insulins: expanding options in diabetes management.
    Gerich JE
    Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report.
    Nguyen AD; Luong CQ; Chu HC; Nguyen VKD; Nguyen CV; Nguyen TA; Nguyen QH; Mai TD; Nguyen DV; Nguyen BQ; Tran TH; Dao PV; Nguyen DT; Nguyen NN; Do SN
    BMC Endocr Disord; 2019 Nov; 19(1):121. PubMed ID: 31711488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus].
    Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ
    Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion.
    Nemoto KI; Ugi S; Ogaku S; Nakaizumi N; Kato T; Fuse K; Sekine O; Morino K; Tanaka T; Maegawa H
    Diabetol Int; 2016 Dec; 7(4):447-450. PubMed ID: 30603298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes.
    Chen JW; Frystyk J; Lauritzen T; Christiansen JS
    Eur J Endocrinol; 2005 Dec; 153(6):907-13. PubMed ID: 16322398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin allergy can be successfully managed by a systematic approach.
    Haastrup MB; Henriksen JE; Mortz CG; Bindslev-Jensen C
    Clin Transl Allergy; 2018; 8():35. PubMed ID: 30258565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes.
    Gupta V; Baabbad R; Hammerby E; Nikolajsen A; Shafie AA
    J Med Econ; 2015 Apr; 18(4):263-72. PubMed ID: 25426701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetic and pharmacodynamic properties of biphasic insulin Aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin Aspart 30 (BIAsp 30).
    Bott S; Tusek C; Heinemann L; Friberg HH; Heise T
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):545-50. PubMed ID: 16235159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Allergic and pseudoallergic reactions of the urticaria skin and mucous membranes due to food components with special reference to food and RAST].
    Illig L; Paul E
    Z Hautkr; 1984 Jun; 59(12):793-813. PubMed ID: 6464526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.
    Heise T; Stender-Petersen K; Hövelmann U; Jacobsen JB; Nosek L; Zijlstra E; Haahr H
    Clin Pharmacokinet; 2017 Jun; 56(6):649-660. PubMed ID: 27878566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.